Drawing for SEER HEALTH

USPTO serial 79340315

SEER HEALTH

Reviewed by CopyMark Law Group

Status 605
Filing date
Status date
Registration date
—
Examiner
BARRETT, LEAH N
Law office
TMEG LAW OFFICE 106

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with SEER HEALTH?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

CHARLES G. ZUG

CHARLES G. ZUG NELSON MULLINS RILEY & SCARBOROUGH LLP301 SOUTH COLLEGE STREETSUITE 2300, IP DEPARTMENTCHARLOTTE, NC 28202

Goods and services

ClassDescriptionStatusFirst use
044Advisory services relating to medical problems; advisory services relating to medical services; health care consultancy services, namely, consulting services in the field of medical care; medical advisory services; medical analysis services relating to the treatment of patients; medical assistance; medical care services; medical counselling; medical testing and medical analysis services, all for diagnostic purposes; providing medical information; medical services; medical services in the field of neurology; medical advisory services relating to the treatment of epilepsy; medical advisory services relating to the management of epilepsyABANDONED—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Nov 7, 2025NREPNEW REPRESENTATIVE AT IB RECEIVED—
Jun 13, 2025FINTFINAL DECISION TRANSACTION PROCESSED BY IB—
May 26, 2025FICSFINAL DISPOSITION NOTICE SENT TO IB—
May 25, 2025FICRFINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB—
Apr 30, 2025LIMNLIMITATION FROM THE IB EXAMINED, NO ACTION IS NEEDED—
Oct 11, 2024ADCHCHANGE OF NAME/ADDRESS REC'D FROM IB—
Sep 29, 2024LIMGLIMITATION OF GOODS RECEIVED FROM IB—
May 27, 2024GPNXNOTIFICATION PROCESSED BY IB—
May 25, 2024MAB5ABANDONMENT NOTICE E-MAILED - AFTER PUBLICATION—
May 25, 2024ABN5ABANDONMENT - AFTER PUBLICATION—
May 24, 2024EXARTEAS EXPRESS ABANDONMENT RECEIVED—
May 21, 2024NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
May 21, 2024PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
May 8, 2024OPNSNOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB—
May 8, 2024OP2RNOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB—
May 1, 2024NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Apr 17, 2024CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Apr 17, 2024XAECEXAMINER'S AMENDMENT ENTERED—
Apr 17, 2024GNENNOTIFICATION OF EXAMINERS AMENDMENT E-MAILED—
Apr 17, 2024GNEAEXAMINERS AMENDMENT E-MAILED—
Apr 17, 2024CNEAEXAMINERS AMENDMENT -WRITTEN—
Apr 12, 2024EXPTEXPARTE APPEAL TERMINATED—
Mar 1, 2024EXFBEXPARTE APPEAL DISMISSED - FAILURE TO FILE BRIEF—
Nov 6, 2023OPNXNOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB—
Oct 18, 2023OPNSNOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB—
Oct 18, 2023OPNRNOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB—
Aug 23, 2023EXPIEX PARTE APPEAL-INSTITUTED—
Aug 23, 2023EXAFEXPARTE APPEAL RECEIVED AT TTAB—
May 4, 2023CHANAPPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED—
May 4, 2023TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
May 4, 2023ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
May 4, 2023REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
May 4, 2023COARTEAS CHANGE OF OWNER ADDRESS RECEIVED—
Feb 23, 2023GNFNNOTIFICATION OF FINAL REFUSAL EMAILED—
Feb 23, 2023GNFRFINAL REFUSAL E-MAILEDA final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon.
Feb 23, 2023CNFRFINAL REFUSAL WRITTENA final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon.
Jan 20, 2023TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Jan 19, 2023CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Jan 19, 2023TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Aug 10, 2022RFNTREFUSAL PROCESSED BY IB—
Jul 19, 2022RFCSNON-FINAL ACTION MAILED - REFUSAL SENT TO IB—
Jul 19, 2022RFRRREFUSAL PROCESSED BY MPU—
Jul 15, 2022RFCRNON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW—
Jul 14, 2022CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jul 13, 2022DOCKASSIGNED TO EXAMINER—
May 17, 2022MAFRAPPLICATION FILING RECEIPT MAILED—
May 13, 2022NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
May 12, 2022REPRSN ASSIGNED FOR SECT 66A APPL FROM IB—

Frequently asked questions

Related guidance